What Are Antibody-drug Conjugates?
Antibody-drug conjugates, or ADCs, are increasingly common cancer therapies. But what are they? How do they work? And how...
Cancer Research CatalystThe Official Blog of the American Association for Cancer Research
Antibody-drug conjugates, or ADCs, are increasingly common cancer therapies. But what are they? How do they work? And how...
Elizabeth M. Jaffee, Timothy R. Rebbeck, and Andrea Cercek spoke about the AACR's conference on the rise of early-onset...
The second AACR Childhood Cancer Predisposition Workshop gathered experts from around the world to refine surveillance strategies, expanding recommendations...
New research is redefining the role of surgery, revealing approaches to help cancer patients preserve their organs, function, and...
New research highlights approaches that could provide better long-term quality of life for childhood cancer survivors into adulthood.
For August 2025, the editors of AACR's journals highlighted studies on liquid biopsy for brain cancer, new treatment strategies...
The 2025 AACR Journal Awards recognized outstanding researchers whose studies made in a significant impact in their respective domains.
Researchers highlighted AI's potential to enhance clinical cancer care, including to improve diagnosis, guide precision medicine, and more.
New clinical trials are exploring an array of CAR T-cell approaches for children with cancers of the brain and...
The AACR hosted a Virtual Patient Advocate Forum in July 2025 on technology’s role in cancer care.
Researchers highlighted AI's potential to enhance cancer research, including to discover cancer drivers and new therapeutic opportunities.